Trial Profile
A randomised, placebo-controlled, titration-to-effect, crossover study of study drug 038 in patients with chronic low back pain
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 30 Aug 2013
Price :
$35
*
At a glance
- Drugs Oxycodone/naloxone (Primary)
- Indications Back pain
- Focus Therapeutic Use
- 25 Jul 2008 New trial record.